Conexeu

About Conexeu

Conexeu is a regenerative medicine company focused on collagen-based technologies for regenerative aesthetics and tissue reconstruction. Their CXU™ collagen scaffold platform combines injectable materials, bio-stimulators, and tissue repair to promote on-demand regeneration for applications ranging from facial rejuvenation to wound healing and larger-volume tissue reconstruction. The company emphasizes translational research and clinical validation, with leadership drawn from aesthetics, wound care, and medical device sectors. Conexeu aims to bridge aesthetics and regenerative medicine on a global scale, advancing biomimetic collagen scaffolds and hydro-gel formulations to restore tissue and improve patient outcomes.